X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
index medicus (9) 9
cancer (7) 7
expression (5) 5
female (5) 5
life sciences (5) 5
male (5) 5
abridged index medicus (4) 4
adult (4) 4
middle aged (4) 4
aged (3) 3
angiogenesis (3) 3
animals (3) 3
care and treatment (3) 3
hematology (3) 3
internal medicine (3) 3
ligands (3) 3
medicine, general & internal (3) 3
stem cells (3) 3
transplantation (3) 3
analysis (2) 2
binding (2) 2
breast cancer (2) 2
cell line, tumor (2) 2
cell survival (2) 2
chemotherapy (2) 2
clinical trials (2) 2
cytarabine - administration & dosage (2) 2
drug therapy (2) 2
growth (2) 2
immunosuppressive agents - adverse effects (2) 2
kinases (2) 2
lymphoma, mantle-cell - therapy (2) 2
medical prognosis (2) 2
metastasis (2) 2
mice, inbred nod (2) 2
mice, scid (2) 2
multicenter (2) 2
neuropilin (2) 2
oncology (2) 2
receptor (2) 2
therapy (2) 2
tumors (2) 2
vascular endothelial growth factor (2) 2
xenograft model antitumor assays (2) 2
1712-1778 (1) 1
1st-line treatment (1) 1
[ sdv ] life sciences [q-bio] (1) 1
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
aberrations (1) 1
activation (1) 1
acute toxicity (1) 1
adolescent (1) 1
age distribution (1) 1
aged, 80 and over (1) 1
aggregation (1) 1
angiogenesis inhibitors - chemistry (1) 1
angiogenesis inhibitors - pharmacology (1) 1
antagonists (1) 1
anti-angiogenic compound (1) 1
anti-vegf (1) 1
antiangiogenic agents (1) 1
anticancer properties (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - chemistry (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antineoplastic protocols (1) 1
apoptosis - drug effects (1) 1
asialoglycoproteins - blood (1) 1
asthenia (1) 1
asthenia - chemically induced (1) 1
authors, french (1) 1
autografts (1) 1
azathioprine (1) 1
b-virus reactivation (1) 1
biocompatibility (1) 1
biographies (1) 1
biography (1) 1
biomarkers - blood (1) 1
biomarkers - metabolism (1) 1
blood donors (1) 1
blood transfusion (1) 1
bone marrow cells - cytology (1) 1
bone marrow cells - immunology (1) 1
bone-marrow-transplantation (1) 1
bowel disease (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - pathology (1) 1
burden (1) 1
c-virus (1) 1
calcein-am (1) 1
calcein‐am (1) 1
cancer therapies (1) 1
cd47 (1) 1
cd47 antigen - blood (1) 1
cell & tissue engineering (1) 1
cell adhesion & migration (1) 1
cell culture (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9701, pp. 1617 - 1625
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10069, pp. 612 - 620
Journal Article
Journal Article
Journal Article
Cancer Letters, ISSN 0304-3835, 02/2018, Volume 414, pp. 88 - 98
Neuropilin-1 (NRP-1) is an extra-cellular receptor for the main Vascular Endothelial Growth Factor over-expressed in tumour tissues, VEGF-A . Consequently,... 
Anti-angiogenic compound | Tumour cell viability reduction | Neuropilin antagonists | In vivo tumour growth inhibition | In vivo tumour growth inhibition | VEGF | RECEPTOR | CANCER | DISCOVERY | PEPTIDOMIMETICS | ONCOLOGY | GROWTH | REGULATORY T-CELLS | INHIBITORS | EXPRESSION | BINDING | Neoplasms - metabolism | Neuropilin-1 - metabolism | Humans | Cells, Cultured | Angiogenesis Inhibitors - pharmacology | Mice, SCID | Neuropilin-1 - antagonists & inhibitors | Mice, Knockout | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Tumor Burden - drug effects | Survival Analysis | Cell Line, Tumor | Mice, Inbred NOD | Cell Proliferation - drug effects | Molecular Structure | Neoplasms - pathology | Angiogenesis Inhibitors - chemistry | Antimitotic agents | Care and treatment | Endothelial growth factors | Antineoplastic agents | Analysis | Cancer | Toxicity | Xenotransplantation | Neuropilin | Cytotoxicity | Antagonists | Metastasis | Kinases | Tissues | Cancer therapies | Optimization | Cell adhesion & migration | Anticancer properties | Angiogenesis | Xenografts | Antiangiogenic agents | Biocompatibility | Vascular endothelial growth factor | Growth factors | Cell survival | Hematology | Breast cancer | Tumor cell lines | Overexpression | Sulfonamides | Medical prognosis | Collagen | Cell lines | Ligands | Prostate cancer | Viability | Tumors | Acute toxicity | Index Medicus | Life Sciences
Journal Article
Cancer Letters, ISSN 0304-3835, 2014, Volume 349, Issue 2, pp. 120 - 127
Journal Article
Clinical Immunology, ISSN 1521-6616, 09/2018, Volume 194, pp. 75 - 79
There is no therapeutic agent approved in cutaneous mastocytosis and mast cell activation syndrome. We report the efficacy of in four patients with cutaneous... 
Mastocytosis | Mast cell activation diseases | Mast cells | Hydroxychloroquine | Mast cell activation syndrome | CONSENSUS PROPOSAL | LUPUS-ERYTHEMATOSUS | CLASSIFICATION | DISORDERS | IMMUNOLOGY | DIAGNOSTIC-CRITERIA | OPTIONS
Journal Article
Journal Article